Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-08-12Clinical Trial Update: Acute Effects of Medium Chain Triglyceride (MCT) Nutritional Ketosis on Parkinson's Disease (PD) Symptoms and Biomarkers (MCT-PD) [Phase 1]
Phase 1 study assessing acute effects of medium-chain triglyceride–induced nutritional ketosis on symptoms and biomarkers in Parkinson's dis…
-
CLINICAL_TRIALS trial_result · 2022-08-10Clinical Trial Update: Assessing the Pharmacokinetics, Safety, Tolerability and Efficacy of Continuous Oral Levodopa Via the DopaFuse® Delivery System in Parkinson's Disease Patients [Phase 2]
Phase 2 trial evaluating pharmacokinetics, safety, tolerability, and efficacy of continuous oral Levodopa via DopaFuse delivery in Parkinson…
-
CLINICAL_TRIALS trial_result · 2022-08-08Clinical Trial Update: Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients [Phase 2]
A Phase 2 clinical trial evaluated metabolic cofactor supplementation in patients with Alzheimer's disease and Parkinson's disease; study st…
-
CLINICAL_TRIALS trial_result · 2022-08-08Clinical Trial Update: Effect of Doxycycline in Levodopa Treated Parkinson's Disease Patients [Phase 2]
A Phase 2 clinical trial is investigating the effect of doxycycline in patients with Parkinson's disease treated with levodopa.
-
FDA approval · 2022-07-28FDA Approved: DHIVY — Supplemental Application (Avion Pharmaceuticals, LLC)
FDA approved a supplemental application for DHIVY, a carbidopa-levodopa product from Avion Pharmaceuticals, LLC. The action approves changes…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-07-14Clinical Trial Update: Physiological Flow of Liquids Used in Dysphagia Management (Neuro)
Completed clinical trial evaluating physiological flow of liquids used in dysphagia management in ALS and Parkinson disease patients; result…
-
CLINICAL_TRIALS trial_result · 2022-07-05Clinical Trial Update: Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson Disease [Phase 2]
Phase 2 clinical trial evaluating imaging to monitor and predict progression in Parkinson disease. Completed study.
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: A Study to Assess the Safety and Effectiveness of Pridopidine Compared to Placebo in the Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease [Phase 2]
Phase 2 trial assessing pridopidine vs placebo for safety and effectiveness in levodopa-induced dyskinesia in Parkinson's disease; study ter…
-
FDA approval · 2022-06-30FDA Approved: DHIVY — Supplemental Application (Avion Pharmaceuticals, LLC)
The FDA approved a supplemental application for DHIVY (carbidopa-levodopa) from Avion Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: Modulation of GABA-A Receptors in Parkinson Disease-Flumazenil Arm [Phase 1, Phase 2]
A randomized clinical trial exploring modulation of GABA-A receptors using a flumazenil arm in Parkinson disease has completed Phase 1 and P…
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: EC50 of Dexmedetomidine in Deep Brain Stimulation Implantation of Patients With Parkinson's Disease [Phase 4]
Phase 4 trial update examining the EC50 of dexmedetomidine during deep brain stimulation implantation in patients with Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2022-06-06Clinical Trial Update: A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease [Phase 2]
Phase 2 trial updates the pharmacokinetics and pharmacodynamics of IPX203 in adults with advanced Parkinson's disease; results posted.
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Outcomes Mandate National Integration With Cannabis as Medicine [Phase 2]
Phase 2 clinical trial update focusing on integrating cannabis as medicine for various chronic pain conditions, with status currently UNKNOW…
-
CLINICAL_TRIALS trial_result · 2022-05-24Clinical Trial Update: Safety and Efficacy of DA-9805 for Parkinson's Disease [Phase 2]
Phase 2 trial results for DA-9805 in Parkinson's disease have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Apomorphine Effects on Pain in Parkinson's Disease [Phase 2, Phase 3]
A clinical trial update regarding apomorphine’s effects on pain in Parkinson’s disease across Phase 2 and Phase 3 is listed, with the status…
-
CLINICAL_TRIALS trial_result · 2022-05-17Clinical Trial Update: Botulinum Toxin Type A for Foot Dystonia-associated Pain in Parkinson's Disease [Phase 2, Phase 3]
Clinical trial update on botulinum toxin type A for foot dystonia-associated pain in Parkinson's disease across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: A Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's Disease [Phase 2]
Phase 2 clinical trial update for KDT-3594 in Japanese patients with early Parkinson's disease has completed.
-
FDA approval · 2022-05-11FDA Approved: ROPINIROLE — Original Application (Solco Healthcare US, LLC)
The FDA approved Solco Healthcare US, LLC's original application for a generic ropinirole product, marking approval to treat conditions incl…
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment [Phase 2]
Phase 2 study assessing safety of GRF6021 infusions in Parkinson's disease with cognitive impairment; trial completed with results posted in…
-
FDA approval · 2022-05-05FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (ScieGen Pharmaceuticals Inc)
The FDA approved a supplemental application for ScieGen Pharmaceuticals Inc to market a generic pramipexole dihydrochloride product for the …
-
CLINICAL_TRIALS trial_result · 2022-05-03Clinical Trial Update: Safety and Biomarker Study of PTC-589 in Participants With Parkinson's Disease [Phase 2]
Phase 2 safety and biomarker study of PTC-589 in Parkinson's disease has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: Efficacy of Oral Administration of Trehalose in Patients With Parkinson Disease [Phase 4]
Phase 4 trial evaluating the efficacy of oral trehalose in patients with Parkinson disease.
-
CLINICAL_TRIALS trial_result · 2022-04-29Clinical Trial Update: Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients [Phase 2]
Phase 2 clinical trial assessing AVP-923 for levodopa-induced dyskinesia in Parkinson's disease completed with results posted.
-
FDA approval · 2022-04-27FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for bromocriptine mesylate submitted by Zydus Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS withdrawal · 2022-04-14Clinical Trial Update: Study of Zonisamide in Early Parkinson Disease [Phase 2, Phase 3]
A phase 2/3 trial evaluating zonisamide in early Parkinson disease has been withdrawn.